1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Patient characteristicsa
Characteristic Result No. of patients 80 Age, mean (yr) 48 (SD, 16) HGG 43 (54) IDHmt 46 (58) Male sex 49 (61) Postcontrast enhancement 46 (58) Necrosis 31 (39) T2 FLAIR mismatch 6 (8) Hemorrhage 24 (30)
Note:—HGG indicates high-grade glioma; IDHmt, IDH-mutant.
↵a Unless otherwise noted, data represent the number of patients; data in parentheses are percentages.